The mucor mycosis epidemic: a call for heightened surveillance of pregnant COVID-19 women

Abstract

As India was struugling with the second coronavirus wave, a new epidemic in the form of Mucormycosis came as a challenge all of a sudden. The overburdened health care system suffered a complete set back. At this moment, we cannot forget the vulnerable pregnant population of the country. With India being the capital of gestational diabetes, she stands the greatest risk of suffering the brunt of its aftermath. Prevailing malnutrition, anemia and micronutrient deficiencies which are rampant during pregnancy make the women of low-middle income countries more vulnerable to this fungal epidemic. All efforts must be undertaken to improve antenatal care and strengthen vigilance, detection and treatment of gestational diabetes across the country.